Most kidney transplant candidates are on the waiting list at a transplant center in their local area. In most cases, transplant centers use the local OPO or, if there is more than one OPO in an area, transplant centers may choose the OPO to list their transplant patients. According to a ...
Prevalence and outcomes of multiple-listing for cadaveric kidney and liver transplantation - MerionMerion RM, Guidinger MK, Newmann JM, Ellison MD, Port FK, Wolfe RA. Prevalence and outcomes of multiple-listing for cadav- eric kidney and liver transplantation. Am J Transplant 2004; 4: 94-100...
Transplant. Rev. 1997; 11: 70–75.Ozminkowski RJ, Hassol A, White A, Murphy M, Dennis JM, Shield CF. Socioeconomic factors and multiple listing for cadav- eric kidney transplantation among Medicare End Stage Renal Dis- ease Program beneficiaries. Transplant Rev 1997; 11: 70-75....
We evaluated the association between multilisting (ML) status and access to a deceased donor kidney transplant (DDKT) to determine if ML provides a long-term advantage regarding wait-list mortality and recipient outcomes. Materials and Methods Candidates between January 2010 and October 2017 were ...
Methods We reviewed the records of 225 adult kidney transplants done consecutively at our institution. Twenty-nine patients (12.8%) had grafts with multiple renal arteries. We analyzed the incidence of post-transplant hypertension and vascular complications, mean creatinine levels, patient and graft ...
The results showed that kidney transplant survival could be predicted by regression models and ANNs, with good prediction discrimination and model calibration. In AUC (area under the ROC curve) measurements, logistic regression ranged from 0.71 to 0.81; single-output ANNs from 0.72 to 0.82; Cox ...
All donors were evaluated for renal vascular function and split renal function (SRF) using computed tomography and technetium-99m mercaptoacetyltriglycine renal scintigraphy before surgery. The transplant kidneys were determined as follows: (i) if the SRF was ≥10%, the kidney with low function wa...
EP: 2.Eligibility Factors in Multiple Myeloma Transplant EP: 3.Multiple Myeloma Care: Pharmacist Team Collaboration EP: 4.Multiple Myeloma Regimen Comparisons EP: 5.Pharmacist's Role in Enhancing Multiple Myeloma Care EP: 6.Choosing Multiple Myeloma Regimens EP: 7.Pharmacists' Patient Counseling Role...
Autologous Stem Cell Transplant for a Patient with Relapsing-Remitting Multiple Sclerosis We report herein the patterns of type 1 diabetes recurrence in a simultaneous pancreas-kidney transplant (SPK) recipient, in the absence of rejection. A 38... KA Ibrahim - 《Biology of Blood & Marrow Transp...
Kidney failure Neuropathies See Presentation for more detail. Diagnosis MM is often discovered through routine blood screening when patients are being evaluated for unrelated problems. In one third of patients, the condition is diagnosed after a pathologic fracture occurs, usually involving the axial...